{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-032798","form_type":"8-K","ticker":"AMIX","cik":"0001617867","company_name":"Autonomix Medical, Inc.","filed_at":"2025-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.935693+00:00","generated_at":"2026-05-17T00:53:26.085935+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Autonomix Medical stockholders approve reverse split, expanded equity plan at annual meeting","bullets":["All five director nominees elected; Forvis Mazars ratified as auditor for FY ending Mar 2026.","Reverse stock split authorized at ratio of 1-for-2 to 1-for-25, board discretion for one year.","Amended and restated 2023 Equity Incentive Plan approved, increasing authorized shares by 1.9M to ~2.27M.","Issuance of >20% of outstanding common stock to Lincoln Park Capital Fund, LLC approved.","Total shares voted 2,871,639 (48% of outstanding) constituting a quorum."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-032798","json":"https://secwatch.observer/filing/0001437749-25-032798.json","markdown":"https://secwatch.observer/filing/0001437749-25-032798.md","text":"https://secwatch.observer/filing/0001437749-25-032798.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1617867/000143774925032798/0001437749-25-032798-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1617867/000143774925032798/amix20251030_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:53:26.085935+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}